Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.

Hematology / Oncology @Point of Care Podcasts
Claim This Podcastby @Point of Care
Podcast Authority
Beta
Podcast Overview
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
Language
🇺🇲
Publishing Since
7/31/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Hematology / Oncology @Point of Care Podcasts
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

April 24, 2026
S28:E2 – Randomized Controlled Trials and Real-World Evidence: Efficacy Across Patient Subgroups with LR-MDS
<p>In this podcast episode, Andrew Kuykendall, MD, and Sangeetha Venugopal, MD, MS they review the clinical trial and real-world evidence on the efficacy and safety of currently available therapies for patients with lower-risk myelodysplastic syndrome (LR-MDS)-associated anemia. Their thought-provoking discussion will give an overview of the pertinent publications while highlighting the clinical implications of this data, in practice. </p> <p>Visit <a href="https://suitehome.atpointofcare.com/library/2729.02/page/0" rel="nofollow">https://suitehome.atpointofcare.com/library/2729.02/page/0</a></p> <p>to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.</p>

April 24, 2026
S28:E1 – Clearing the Confusion on Dosing for Luspatercept in LR-MDS
<p>In this podcast episode, Andrew Kuykendall, MD, and Sangeetha Venugopal, MD, MS explore dose escalation strategies for the erythroid maturation agent (EMA), luspatercept, in patients with lower-risk myelodysplastic syndrome (LR-MDS). Their engaging discussion will give an overview of the pertinent clinical trial efficacy and safety data and recent changes to the prescribing information, as well as delving into how they both apply this information in their clinical practices.</p> <p>Visit <a href="https://suitehome.atpointofcare.com/library/2729.01/page/0" rel="nofollow">https://suitehome.atpointofcare.com/library/2729.01/page/0</a></p> <p>to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn</p>

January 15, 2026
S27:E3 – Treating NSCLC Without Actionable Mutations: The Role of TROP2 ADCs
<p>In this episode, our expert faculty, medical oncologist Dr. Heather Wakelee, and pathologist Dr. Anil Parwani, explore targeted antibody-drug conjugates (ADCs) in the management of non-small cell lung cancer (NSCLC) without actionable genomic alterations (AGAs). Discussion will include why trophoblast cell surface antigen 2 (TROP2) is a promising target in NSCLC, quantitative continuous scoring (QCS) as a predictive biomarker, current efficacy and safety data from clinical trials, and best practices for monitoring and mitigating ADC-associated adverse events (AEs). </p> <p>Visit <a href="https://suitehome.atpointofcare.com/library/2720.03/page/0" rel="nofollow">https://suitehome.atpointofcare.com/library/2720.03/page/0</a> to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.</p>
89 total episodes available
Recent guests on Hematology / Oncology @Point of Care Podcasts
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Joyce O’Shaughnessy
Guest
Marissa Marti-Smith
Guest
Joyce O’Shaughnessy MD
Guest
Reshma Mahtani MD
Guest
Dr Michelle Shiller
Guest
Dr Charu Aggarwal
Guest
Dr Jacob Sands
Guest
Similar Podcasts
Discover related shows you might enjoy

Oncology Brothers
Oncology Brothers

OncLive® On Air
OncLive® On Air

Two Onc Docs
Sam and Karine

The Uromigos
The Uromigos

The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast

This Week in Cardiology
Medscape

Doctors and Litigation: The L Word
Gita Pensa MD

GU Cast
Professor Declan Murphy & Dr Renu Eapen

Oncology Decoded
Oncology Decoded
Deep-dive analytics for Hematology / Oncology @Point of Care Podcasts
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Hematology / Oncology @Point of Care Podcasts?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.